Yue XF et al. |
Cytotoxic activity of trewiasine in 4 human cancer cell lines and 5 murine tumors. |
1992 |
Zhongguo Yao Li Xue Bao |
pmid:1442109
|
Fan YJ et al. |
[Effect of maytansine on the cell cycle of Ehrlich ascites carcinoma cells in mice]. |
1985 |
Zhongguo Yao Li Xue Bao |
pmid:3158164
|
Yang JL et al. |
[Antitumor activity of trewiasine in vitro and in vivo]. |
1988 |
Zhongguo Yao Li Xue Bao |
pmid:3256213
|
Wang XF et al. |
[Studies on the antitumor constituents of Maytenus confertiflora Luo et Chen (Celastraceae). II. Isolation and characterization of maytansine and maytanprine from the stems]. |
1981 |
Yao Xue Xue Bao |
pmid:7324964
|
Fan YJ et al. |
[Use of 1,2:5,6-dianhydrogalactitol in combination with maytansine in experimental tumor therapy]. |
1983 |
Yao Xue Xue Bao |
pmid:6677049
|
Vilela MD et al. |
Progressively Enlarging Cerebellar Hematoma Concurrent with T-DM1 Treatment. |
2018 |
World Neurosurg |
pmid:29274446
|
Niell HB et al. |
Effect of concentration and time of drug exposure on clonal growth of murine bladder cancer. |
1985 |
Urology |
pmid:2579500
|
Milowsky MI et al. |
Phase 1/2 multiple ascending dose trial of the prostate-specific membrane antigen-targeted antibody drug conjugate MLN2704 in metastatic castration-resistant prostate cancer. |
2016 |
Urol. Oncol. |
pmid:27765518
|
Roviello G et al. |
Monoclonal antibodies-based treatment in gastric cancer: current status and future perspectives. |
2016 |
Tumour Biol. |
pmid:26566626
|
Faião-Flores F et al. |
Bcl-2 family proteins and cytoskeleton changes involved in DM-1 cytotoxic effect on melanoma cells. |
2013 |
Tumour Biol. |
pmid:23341182
|
De Angelis C et al. |
Long-term disease control with lapatinib and capecitabine in a patient with HER2-positive metastatic breast cancer pretreated with trastuzumab and trastuzumab-emtansine. |
2013 May-Jun |
Tumori |
pmid:24158083
|
Poon KA et al. |
Preclinical safety profile of trastuzumab emtansine (T-DM1): mechanism of action of its cytotoxic component retained with improved tolerability. |
2013 |
Toxicol. Appl. Pharmacol. |
pmid:24035823
|
Wehrli W |
Ansamycins. Chemistry, biosynthesis and biological activity. |
1977 |
Top Curr Chem |
pmid:74108
|
Hull RN et al. |
Studies on tissue culture produced plasminogen activator. I. Preliminary observations and the enhancing effect of colchicine and other antimitotic agents. |
1977 |
Thromb. Res. |
pmid:18812
|
Liang Y et al. |
A Nanosystem of Amphiphilic Oligopeptide-Drug Conjugate Actualizing Both αvβ3 Targeting and Reduction-Triggered Release for Maytansinoid. |
2017 |
Theranostics |
pmid:28900511
|
Vankemmelbeke M and Durrant L |
Third-generation antibody drug conjugates for cancer therapy--a balancing act. |
2016 |
Ther Deliv |
pmid:26893243
|
Sieber SM et al. |
Teratogenic and cytogenetic effects of some plant-derived antitumor agents (vincristine, colchicine, maytansine, VP-16-213 and VM-26) in mice. |
1978 |
Teratology |
pmid:694777
|
Kosmin M et al. |
Splenic Enlargement and Bone Marrow Hyperplasia in Patients Receiving Trastuzumab-Emtansine for Metastatic Breast Cancer. |
2017 |
Target Oncol |
pmid:28110417
|
Diéras V and Bachelot T |
The success story of trastuzumab emtansine, a targeted therapy in HER2-positive breast cancer. |
2014 |
Target Oncol |
pmid:23852665
|
Iwasaki S |
[Inhibitors of tubulin assembly: specially on rhizoxin-maytansine site ligands]. |
1993 |
Tanpakushitsu Kakusan Koso |
pmid:8210422
|
Janjigian YY and Braghiroli MI |
Current Progress in Human Epidermal Growth Factor Receptor 2 Targeted Therapies in Esophagogastric Cancer. |
2017 |
Surg. Oncol. Clin. N. Am. |
pmid:28279471
|
Cox K et al. |
Emerging Therapeutic Strategies in Breast Cancer. |
2017 |
South. Med. J. |
pmid:28973703
|
Bhardwaj AS et al. |
A case of vasculitis in a breast cancer patient treated with T-DM1. |
2014 |
Semin. Oncol. |
pmid:25440614
|
Müller P et al. |
Trastuzumab emtansine (T-DM1) renders HER2+ breast cancer highly susceptible to CTLA-4/PD-1 blockade. |
2015 |
Sci Transl Med |
pmid:26606967
|
Shen K et al. |
Safety and Efficacy of Trastuzumab Emtansine in Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: a Meta-analysis. |
2016 |
Sci Rep |
pmid:26979925
|
Pan W et al. |
Asm8, a specific LAL-type activator of 3-amino-5-hydroxybenzoate biosynthesis in ansamitocin production. |
2013 |
Sci China Life Sci |
pmid:23832249
|
Ito Y |
[Progress of molecularly targeted therapy for breast cancer]. |
2012 |
Rinsho Ketsueki |
pmid:22687976
|
Lin CM et al. |
Binding of maytansine to tubulin: competition with other mitotic inhibitors. |
1981 |
Res. Commun. Chem. Pathol. Pharmacol. |
pmid:7255878
|
Lanshoeft C et al. |
Analysis of small molecule antibody-drug conjugate catabolites in rat liver and tumor tissue by liquid extraction surface analysis micro-capillary liquid chromatography/tandem mass spectrometry. |
2016 |
Rapid Commun. Mass Spectrom. |
pmid:26969923
|
Lazar AC et al. |
Analysis of the composition of immunoconjugates using size-exclusion chromatography coupled to mass spectrometry. |
2005 |
Rapid Commun. Mass Spectrom. |
pmid:15945030
|
Gurtner K et al. |
Combined treatment of the immunoconjugate bivatuzumab mertansine and fractionated irradiation improves local tumour control in vivo. |
2012 |
Radiother Oncol |
pmid:22100655
|
Marcoux J et al. |
Native mass spectrometry and ion mobility characterization of trastuzumab emtansine, a lysine-linked antibody drug conjugate. |
2015 |
Protein Sci. |
pmid:25694334
|
Wang L et al. |
Structural characterization of the maytansinoid-monoclonal antibody immunoconjugate, huN901-DM1, by mass spectrometry. |
2005 |
Protein Sci. |
pmid:16081651
|
Kubizek F et al. |
Status Quo in Antibody-Drug Conjugates - Can Glyco- Enzymes Solve the Current Challenges? |
2017 |
Protein Pept. Lett. |
pmid:28741467
|
Sinha S and Jain S |
Natural products as anticancer agents. |
1994 |
Prog Drug Res |
pmid:7916160
|
Arvanitis CD et al. |
Mechanisms of enhanced drug delivery in brain metastases with focused ultrasound-induced blood-tumor barrier disruption. |
2018 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:30150398
|
Field JJ et al. |
A previously undescribed tubulin binder. |
2014 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:25187564
|
Prota AE et al. |
A new tubulin-binding site and pharmacophore for microtubule-destabilizing anticancer drugs. |
2014 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:25114240
|
Liu C et al. |
Eradication of large colon tumor xenografts by targeted delivery of maytansinoids. |
1996 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:8710920
|
Baskin F et al. |
Correlation of double-minute chromosomes with unstable multidrug cross-resistance in uptake mutants of neuroblastoma cells. |
1981 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:6943568
|
Rai SS and Wolff J |
The C terminus of beta-tubulin regulates vinblastine-induced tubulin polymerization. |
1998 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:9539723
|
Yu TW et al. |
The biosynthetic gene cluster of the maytansinoid antitumor agent ansamitocin from Actinosynnema pretiosum. |
2002 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:12060743
|
Ismaili N et al. |
[Recent advances in targeted therapies in the treatment of HER2-positive metastatic breast cancer]. |
2013 |
Presse Med |
pmid:23721860
|
Venghateri JB et al. |
Ansamitocin P3 depolymerizes microtubules and induces apoptosis by binding to tubulin at the vinblastine site. |
2013 |
PLoS ONE |
pmid:24124473
|
Chung YC et al. |
Caveolin-1 Dependent Endocytosis Enhances the Chemosensitivity of HER-2 Positive Breast Cancer Cells to Trastuzumab Emtansine (T-DM1). |
2015 |
PLoS ONE |
pmid:26172389
|
Beerli RR et al. |
Sortase Enzyme-Mediated Generation of Site-Specifically Conjugated Antibody Drug Conjugates with High In Vitro and In Vivo Potency. |
2015 |
PLoS ONE |
pmid:26132162
|
Goldmacher VS et al. |
High-affinity accumulation of a maytansinoid in cells via weak tubulin interaction. |
2015 |
PLoS ONE |
pmid:25671541
|
Pullen CB et al. |
Occurrence and non-detectability of maytansinoids in individual plants of the genera Maytenus and Putterlickia. |
2003 |
Phytochemistry |
pmid:12620351
|
Wings S et al. |
A study of the bacterial community in the root system of the maytansine containing plant Putterlickia verrucosa. |
2013 |
Phytochemistry |
pmid:22795602
|
Hinow P et al. |
Modeling the effects of drug binding on the dynamic instability of microtubules. |
2011 |
Phys Biol |
pmid:21836336
|